Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 455

1.

The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations.

Asa SL, Ezzat S, Mete O.

J Clin Med. 2018 Sep 13;7(9). pii: E280. doi: 10.3390/jcm7090280. Review.

2.

Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.

Mete O, Alshaikh OM, Cintosun A, Ezzat S, Asa SL.

Endocr Pathol. 2018 Sep 13. doi: 10.1007/s12022-018-9545-4. [Epub ahead of print]

PMID:
30215160
3.

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, El-Naggar AK, Fernandez-Cuesta L, Klöppel G, McCluggage WG, Moch H, Ohgaki H, Rakha EA, Reed NS, Rous BA, Sasano H, Scarpa A, Scoazec JY, Travis WD, Tallini G, Trouillas J, van Krieken JH, Cree IA.

Mod Pathol. 2018 Aug 23. doi: 10.1038/s41379-018-0110-y. [Epub ahead of print]

PMID:
30140036
4.

Retraction for Wei et al., "The Breast Cancer Susceptibility Gene Product Fibroblast Growth Factor Receptor 2 Serves as a Scaffold for Regulation of NF-κB Signaling".

Wei W, Liu W, Cassol CA, Zheng W, Asa SL, Ezzat S.

Mol Cell Biol. 2018 Jul 30;38(16). pii: e00298-18. doi: 10.1128/MCB.00298-18. Print 2018 Aug 15. No abstract available.

5.

Immunohistochemical Biomarkers in Thyroid Pathology.

Baloch Z, Mete O, Asa SL.

Endocr Pathol. 2018 May 9. doi: 10.1007/s12022-018-9532-9. [Epub ahead of print] Review.

PMID:
29744727
6.

Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms.

Mete O, Asa SL, Giordano TJ, Papotti M, Sasano H, Volante M.

Endocr Pathol. 2018 Jun;29(2):137-149. doi: 10.1007/s12022-018-9525-8. Review.

PMID:
29542002
7.

Immunohistochemical Biomarkers in Pituitary Pathology.

Asa SL, Mete O.

Endocr Pathol. 2018 Jun;29(2):130-136. doi: 10.1007/s12022-018-9521-z. Review.

PMID:
29453601
8.

Epidemiology and biomarker profile of pituitary adenohypophysial tumors.

Mete O, Cintosun A, Pressman I, Asa SL.

Mod Pathol. 2018 Jun;31(6):900-909. doi: 10.1038/s41379-018-0016-8. Epub 2018 Feb 12.

PMID:
29434339
9.

Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Trading Six for a Risky Half Dozen: Reply.

Parente DN, Bongers PJ, Verzijl R, Rotstein LE, Asa SL, Kluijfhout WP, Devon KM, Goldstein DP, Mete O, Pasternak JD.

World J Surg. 2018 Jul;42(7):2279. doi: 10.1007/s00268-018-4505-1. No abstract available.

PMID:
29396615
10.

The evolving diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).

Lloyd RV, Asa SL, LiVolsi VA, Sadow PM, Tischler AS, Ghossein RA, Tuttle RM, Nikiforov YE.

Hum Pathol. 2018 Apr;74:1-4. doi: 10.1016/j.humpath.2017.12.027. Epub 2018 Jan 16. No abstract available.

PMID:
29339178
11.

What's new in pituitary pathology?

Asa SL, Mete O.

Histopathology. 2018 Jan;72(1):133-141. doi: 10.1111/his.13295. Review.

PMID:
29239033
12.

Endocrine pathology: past, present and future.

Asa SL, Mete O.

Pathology. 2018 Jan;50(1):111-118. doi: 10.1016/j.pathol.2017.09.003. Epub 2017 Nov 11. Review.

PMID:
29132721
13.

Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus?

Hernandez-Prera JC, Machado RA, Asa SL, Baloch Z, Faquin WC, Ghossein R, LiVolsi VA, Lloyd RV, Mete O, Nikiforov YE, Seethala RR, Suster S, Thompson LD, Turk AT, Sadow PM, Urken ML, Wenig BM.

Thyroid. 2017 Dec;27(12):1498-1504. doi: 10.1089/thy.2017.0280. Epub 2017 Nov 7.

PMID:
29020884
14.

The retrotransposon gag domain containing protein Rgag4 is an Ikaros target in the pituitary.

Shen Z, Asa SL, Ezzat S.

Mol Cell Endocrinol. 2018 Feb 5;461:188-193. doi: 10.1016/j.mce.2017.09.013. Epub 2017 Sep 14.

PMID:
28919299
15.

Diagnostic and Prognostic Biomarkers of Adrenal Cortical Carcinoma.

Mete O, Gucer H, Kefeli M, Asa SL.

Am J Surg Pathol. 2018 Feb;42(2):201-213. doi: 10.1097/PAS.0000000000000943.

PMID:
28877067
16.

Integrated Pathology Informatics Enables High-Quality Personalized and Precision Medicine: Digital Pathology and Beyond.

Volynskaya Z, Chow H, Evans A, Wolff A, Lagmay-Traya C, Asa SL.

Arch Pathol Lab Med. 2018 Mar;142(3):369-382. doi: 10.5858/arpa.2017-0139-OA. Epub 2017 Aug 29.

PMID:
28849944
17.

Clinical Safety of Renaming Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: Is NIFTP Truly Benign?

Parente DN, Kluijfhout WP, Bongers PJ, Verzijl R, Devon KM, Rotstein LE, Goldstein DP, Asa SL, Mete O, Pasternak JD.

World J Surg. 2018 Feb;42(2):321-326. doi: 10.1007/s00268-017-4182-5.

PMID:
28828746
18.

Pancreatic Neuroendocrine Tumor Producing Insulin and Vasopressin.

Alshaikh OM, Yoon JY, Chan BA, Krzyzanowska MK, Butany J, Asa SL, Ezzat S.

Endocr Pathol. 2018 Mar;29(1):15-20. doi: 10.1007/s12022-017-9492-5.

PMID:
28718084
19.

The epigenetic landscape of differentiated thyroid cancer.

Asa SL, Ezzat S.

Mol Cell Endocrinol. 2018 Jul 5;469:3-10. doi: 10.1016/j.mce.2017.07.012. Epub 2017 Jul 12. Review.

PMID:
28711609
20.

Epigenetics of pituitary tumors: Pathogenetic and therapeutic implications.

Ezzat S, Cheng S, Asa SL.

Mol Cell Endocrinol. 2018 Jul 5;469:70-76. doi: 10.1016/j.mce.2017.07.011. Epub 2017 Jul 12. Review.

PMID:
28711607
21.

Clinical Applications of Whole-slide Imaging in Anatomic Pathology.

Volynskaya Z, Evans AJ, Asa SL.

Adv Anat Pathol. 2017 Jul;24(4):215-221. doi: 10.1097/PAP.0000000000000153. Review.

PMID:
28590953
22.

The evolution of differentiated thyroid cancer.

Asa SL.

Pathology. 2017 Apr;49(3):229-237. doi: 10.1016/j.pathol.2017.01.001. Epub 2017 Mar 7. Review.

PMID:
28279477
23.

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal.

Asa SL, Casar-Borota O, Chanson P, Delgrange E, Earls P, Ezzat S, Grossman A, Ikeda H, Inoshita N, Karavitaki N, Korbonits M, Laws ER Jr, Lopes MB, Maartens N, McCutcheon IE, Mete O, Nishioka H, Raverot G, Roncaroli F, Saeger W, Syro LV, Vasiljevic A, Villa C, Wierinckx A, Trouillas J; attendees of 14th Meeting of the International Pituitary Pathology Club, Annecy, France, November 2016.

Endocr Relat Cancer. 2017 Apr;24(4):C5-C8. doi: 10.1530/ERC-17-0004.

PMID:
28264912
24.

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS; Cancer Genome Atlas Research Network, Pacak K, Nathanson KL, Wilkerson MD.

Cancer Cell. 2017 Feb 13;31(2):181-193. doi: 10.1016/j.ccell.2017.01.001. Epub 2017 Feb 2.

25.

Pituitary acromegaly: not one disease.

Asa SL, Kucharczyk W, Ezzat S.

Endocr Relat Cancer. 2017 Mar;24(3):C1-C4. doi: 10.1530/ERC-16-0496. Epub 2017 Jan 25.

PMID:
28122798
26.

Xanthomatous Hypophysitis Is Associated with Ruptured Rathke's Cleft Cyst.

Duan K, Asa SL, Winer D, Gelareh Z, Gentili F, Mete O.

Endocr Pathol. 2017 Mar;28(1):83-90. doi: 10.1007/s12022-017-9471-x.

PMID:
28120170
27.

Pancreatic Struma with Papillary Thyroid Carcinoma: a Diagnostic Dilemma.

Liu J, Marcaccio MJ, Young JE, Aziz T, Wat J, Asa SL.

Endocr Pathol. 2017 Mar;28(1):91-94. doi: 10.1007/s12022-016-9462-3. No abstract available.

PMID:
28078619
28.

The dangers of parathyroid biopsy.

Kim J, Horowitz G, Hong M, Orsini M, Asa SL, Higgins K.

J Otolaryngol Head Neck Surg. 2017 Jan 7;46(1):4. doi: 10.1186/s40463-016-0178-7.

29.

Progressive epigenetic dysregulation in neuroendocrine tumour liver metastases.

Karpathakis A, Dibra H, Pipinikas C, Feber A, Morris T, Francis J, Oukrif D, Mandair D, Pericleous M, Mohmaduvesh M, Serra S, Ogunbiyi O, Novelli M, Luong T, Asa SL, Kulke M, Toumpanakis C, Meyer T, Caplin M, Beck S, Thirlwell C.

Endocr Relat Cancer. 2017 Feb;24(2):L21-L25. doi: 10.1530/ERC-16-0419. Epub 2017 Jan 3. No abstract available.

PMID:
28049633
30.

Pituitary Adenomas Presenting as Sinonasal or Nasopharyngeal Masses: A Case Series Illustrating Potential Diagnostic Pitfalls.

Hyrcza MD, Ezzat S, Mete O, Asa SL.

Am J Surg Pathol. 2017 Apr;41(4):525-534. doi: 10.1097/PAS.0000000000000784.

PMID:
28009611
31.

FGFR4 polymorphic alleles modulate mitochondrial respiration: A novel target for somatostatin analog action in pituitary tumors.

Ezzat S, Wang R, Pintilie M, Asa SL.

Oncotarget. 2017 Jan 10;8(2):3481-3494. doi: 10.18632/oncotarget.13843.

32.

Ikaros and its interacting partner CtBP target the metalloprotease ADAMTS10 to modulate pituitary cell function.

Shen Z, Asa SL, Ezzat S.

Mol Cell Endocrinol. 2017 Jan 5;439:126-132. doi: 10.1016/j.mce.2016.10.032. Epub 2016 Nov 1.

PMID:
27815209
33.

The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.

Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Solórzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE.

JAMA Surg. 2016 Oct 1;151(10):959-968. doi: 10.1001/jamasurg.2016.2310.

PMID:
27532368
34.

Gonadotrope Tumors.

Asa SL, Ezzat S.

Prog Mol Biol Transl Sci. 2016;143:187-210. doi: 10.1016/bs.pmbts.2016.08.005. Epub 2016 Sep 7. Review.

PMID:
27697203
35.

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Thyroid Carcinoma.

Chiosea S, Asa SL, Berman MA, Carty SE, Currence L, Hodak S, Nikiforov YE, Richardson MS, Seethala RR, Sholl LM, Thompson LD, Wenig BM, Worden F; Members of the Cancer Biomarker Reporting Committee, College of American Pathologists.

Arch Pathol Lab Med. 2017 Apr;141(4):559-563. doi: 10.5858/arpa.2016-0326-CP. Epub 2016 Sep 28. No abstract available.

PMID:
27681332
36.

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MCBV, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA; Cancer Genome Atlas Research Network, Hammer GD, Giordano TJ, Verhaak RGW.

Cancer Cell. 2016 Aug 8;30(2):363. doi: 10.1016/j.ccell.2016.07.013. Epub 2016 Aug 8. No abstract available.

37.

Synchronous Papillary Carcinoma of Thyroid and Lung.

Wang T, Blumer I, Boerner S, Asa SL.

Endocr Pathol. 2016 Sep;27(3):268-70. doi: 10.1007/s12022-016-9435-6. No abstract available.

PMID:
27236534
38.

Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus.

Singh S, Asa SL, Dey C, Kennecke H, Laidley D, Law C, Asmis T, Chan D, Ezzat S, Goodwin R, Mete O, Pasieka J, Rivera J, Wong R, Segelov E, Rayson D.

Cancer Treat Rev. 2016 Jun;47:32-45. doi: 10.1016/j.ctrv.2016.05.003. Epub 2016 May 17. Review.

PMID:
27236421
39.

TFE3-Expressing Perivascular Epithelioid Cell Neoplasm (PEComa) of the Sella Turcica.

Hyrcza MD, Winer DA, Shago M, Au K, Zadeh G, Asa SL, Mete O.

Endocr Pathol. 2017 Mar;28(1):22-26. doi: 10.1007/s12022-016-9434-7.

PMID:
27189222
40.

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MCBV, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA; Cancer Genome Atlas Research Network, Hammer GD, Giordano TJ, Verhaak RGW.

Cancer Cell. 2016 May 9;29(5):723-736. doi: 10.1016/j.ccell.2016.04.002. Erratum in: Cancer Cell. 2016 Aug 8;30(2):363.

41.

Inter-Observer Variation in the Pathologic Identification of Extranodal Extension in Nodal Metastasis from Papillary Thyroid Carcinoma.

Du E, Wenig BM, Su HK, Rowe ME, Haser GC, Asa SL, Baloch Z, Faquin WC, Fellegara G, Giordano T, Ghossein R, LiVolsi VA, Lloyd R, Mete O, Ozbek U, Rosai J, Suster S, Thompson LD, Turk AT, Urken ML.

Thyroid. 2016 Jun;26(6):816-9. doi: 10.1089/thy.2015.0551.

42.

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.

Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, Barletta JA, Wenig BM, Al Ghuzlan A, Kakudo K, Giordano TJ, Alves VA, Khanafshar E, Asa SL, El-Naggar AK, Gooding WE, Hodak SP, Lloyd RV, Maytal G, Mete O, Nikiforova MN, Nosé V, Papotti M, Poller DN, Sadow PM, Tischler AS, Tuttle RM, Wall KB, LiVolsi VA, Randolph GW, Ghossein RA.

JAMA Oncol. 2016 Aug 1;2(8):1023-9. doi: 10.1001/jamaoncol.2016.0386.

43.

Establishment and Characterization of a Human Neuroendocrine Tumor Xenograft.

Yang Z, Zhang L, Serra S, Law C, Wei A, Stockley TL, Ezzat S, Asa SL.

Endocr Pathol. 2016 Jun;27(2):97-103. doi: 10.1007/s12022-016-9429-4.

PMID:
27067082
44.

NG2 targets tumorigenic Rb inactivation in Pit1-lineage pituitary cells.

Tateno T, Nakano-Tateno T, Ezzat S, Asa SL.

Endocr Relat Cancer. 2016 May;23(5):445-56. doi: 10.1530/ERC-16-0013. Epub 2016 Apr 5.

PMID:
27048321
45.

Inter-Observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma.

Su HK, Wenig BM, Haser GC, Rowe ME, Asa SL, Baloch Z, Du E, Faquin WC, Fellegara G, Giordano T, Ghossein R, LiVolsi VA, Lloyd R, Mete O, Ozbek U, Rosai J, Suster S, Thompson LD, Turk AT, Urken ML.

Thyroid. 2016 Apr;26(4):512-7. doi: 10.1089/thy.2015.0508.

46.

High-throughput drug library screening identifies colchicine as a thyroid cancer inhibitor.

Zhang L, Yang Z, Granieri L, Pasculescu A, Datti A, Asa SL, Xu Z, Ezzat S.

Oncotarget. 2016 Apr 12;7(15):19948-59. doi: 10.18632/oncotarget.7890.

47.

Aggressive Pituitary Tumors or Localized Pituitary Carcinomas: Defining Pituitary Tumors.

Asa SL, Ezzat S.

Expert Rev Endocrinol Metab. 2016 Mar;11(2):149-162. doi: 10.1586/17446651.2016.1153422.

PMID:
30058871
48.

Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.

Mete O, Gomez-Hernandez K, Kucharczyk W, Ridout R, Zadeh G, Gentili F, Ezzat S, Asa SL.

Mod Pathol. 2016 Feb;29(2):131-42. doi: 10.1038/modpathol.2015.151. Epub 2016 Jan 8.

49.

An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma.

Papathomas TG, Pucci E, Giordano TJ, Lu H, Duregon E, Volante M, Papotti M, Lloyd RV, Tischler AS, van Nederveen FH, Nose V, Erickson L, Mete O, Asa SL, Turchini J, Gill AJ, Matias-Guiu X, Skordilis K, Stephenson TJ, Tissier F, Feelders RA, Smid M, Nigg A, Korpershoek E, van der Spek PJ, Dinjens WN, Stubbs AP, de Krijger RR.

Am J Surg Pathol. 2016 Apr;40(4):569-76. doi: 10.1097/PAS.0000000000000574.

PMID:
26685085
50.

Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.

Coli A, Asa SL, Fadda G, Scannone D, Chiloiro S, De Marinis L, Lauretti L, Ranelletti FO, Lauriola L.

Eur J Endocrinol. 2016 Mar;174(3):307-14. doi: 10.1530/EJE-15-0586. Epub 2015 Nov 30.

PMID:
26620390

Supplemental Content

Support Center